Skip to main navigation Skip to search Skip to main content

Verdinexor targeting of CRM1 is a promising therapeutic approach against RSV and influenza viruses

  • Jennifer A. Pickens
  • , Ralph A. Tripp

Research output: Contribution to journal › Review article › peer-review

27   Link opens in a new tab Citations (Scopus)
36 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Verdinexor targeting of CRM1 is a promising therapeutic approach against RSV and influenza viruses'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology